Dendritic Cell Marker (CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR) Antibody Panel - Human
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Dendritic Cell Marker (CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR) Antibody Panel - Human (ab254017) is part of the multiplex kits range. Abcam offers high-quality biological reagents and tools including antibodies, proteins, assays, cell lines and lysates.
View Alternative Names
CD103, Integrin alpha-E, HML-1 antigen, Integrin alpha-IEL, Mucosal lymphocyte 1 antigen, ITGAE
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Dendritic Cell Marker (CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR) Antibody Panel - Human (AB254017)
Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized THP-1 (human monocytic leukemia cell line) cells labeling DC-SIGN + DC-SIGNR with ab245115 at 1/100 dilution, followed by a AlexaFluor®488 Goat anti-Rabbit secondary (ab150077) seconday antibody (green) at 1/1000 dilution.
Confocal image showing cytoplasmic and membranous staining in THP-1 cells treated with 10 ng/ml PMA for 18 hours, then serum starved for 8 hours, then 10 ng/ml PMA for 6 hours and add 1000 U IL4 for 2 hours, then add 10% serum for another 22 hours. DC-SIGN expression is induced by PMA plus IL4 in THP-1(PMID : 15070901; PMID : 22675249). DC-SIGNR/CD299 expression is induced by PMA in THP-1 (PMID 30077333). Tubulin was stained using an Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) (ab195889)(red) at 1/200 dilution. The nuclear counterstain was DAPI (Blue).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is AlexaFluor®488 Goat anti-Rabbit secondary (ab150077) at 1/1000 dilution.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Dendritic Cell Marker (CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR) Antibody Panel - Human (AB254017)
Immunohistochemical analysis of paraffin-embedded human skin tissue labeling DC-SIGN + DC-SIGNR with ab245115 at 1/1000 dilution, followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP) secondary antibody. Cytoplasmic staining on dendritic cell-like cells of human skin (PMID : 11859097; PMID : 11859097) is observed. Counterstained with hematoxylin.
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is a ready to use Goat Anti-Rabbit IgG H&L (HRP).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Dendritic Cell Marker (CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR) Antibody Panel - Human (AB254017)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human colon tissue labeling CD103 with purified ab129202 at 1/500. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. ab97051 an HRP-conjugated goat anti-rabbit IgG (H+L) was used as the secondary antibody (1/500).
Negative control using PBS instead of primary antibody (inset).
Counterstained with hematoxylin.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Dendritic Cell Marker (CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR) Antibody Panel - Human (AB254017)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human tonsil tissue labelling TLR7 with unpurified ab124928 at 1/100.
Product details
Dendritic Cell Marker (CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR) Antibody Panel - Human ab254017 contains multiple trial-sized versions of anti-human antibody clones against CD103, LY75 / DEC-205, TLR7, DC-SIGN + DC-SIGNR, specifically selected for high performance in various applications. This panel contains 4 recombinant rabbit monoclonal antibodies against human CD103, LY75/DEC-205, TLR7, DC-SIGN + DC-SIGNR. They are provided as a sampler panel to allow you to easily evaluate each in your required applications.
For guidelines on how to use each antibody within the panel, please consult the individual datasheet for each antibody.
Panel contains:
- Rabbit monoclonal [EPR4166(2)] to CD103 (20 μL) ab129202
- Rabbit monoclonal [EPR5233] to LY75/DEC-205 (20 μL) ab124897
- Rabbit monoclonal [EPR2088(2)] to TLR7 (20 μL) ab124928
- Rabbit monoclonal [EPR22395-72] to DC-SIGN + DC-SIGNR (20 μL) ab245115
Explore our range of antibody sample panels designed to provide you with a variety of trial-size antibodies in a convenient and cost-effective format.
Carrier-free formulations of our recombinant antibodies are also available for easy conjugation to labels of your choice and for multiplex applications. Use our intuitive search and select carrier-free or your label of choice. For bespoke conjugations or large volumes email bespoke@abcam.com.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
LY75/DEC-205 and associated DC markers function in the identification and processing of antigens. They recognize specific ligands and internalize them for processing and presentation to T cells. DEC-205 plays an important role in cross-presentation important for activating cytotoxic T cells. This receptor is part of a larger complex involving other C-type lectin receptors like DC-SIGN that are also present in dendritic cells. These receptors work together to enhance immune responses against pathogens.
Pathways
LY75/DEC-205 and related DC markers are integral to the antigen presentation pathways that activate T lymphocytes. These pathways include the major histocompatibility complex (MHC) class I and II pathways. DEC-205's role in the cross-presentation pathway allows DCs to present antigens to CD8+ T cells often in collaboration with CD103-mediated processes. Related proteins like CD40 and CD80/CD86 are also engaged during T cell priming enhancing immune activation.
Target data
Additional targets
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Immunity & ageing : I & A 21:56 PubMed39169358
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 10: PubMed34992092
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com